The collaboration will include studies of cancer-related microRNAs that were discovered at both Mirna and University of California, San Francisco (UCSF) as well as small RNAs that will be identified in research using mouse and cell models from UCSF.
Matt Winkler, CEO of Mirna, said: “We are very excited about the potential of miRNAs as therapeutic agents and look forward to verifying that the small RNAs can be used to treat patients with cancer. Collaborating with a leading institution like UCSF will ensure rigorous testing of therapeutic miRNAs using the most advanced cancer animal models.”